Marc Watrous

Biotech Executive and Market Access Expert at Chronicled

Marc Watrous, Ph.D., currently serves as the Head of North America Commercial Transformation and New Product Launches at Sanofi, starting in August 2024. A co-founder of A3Access Advisors, LLC, and Novellia, Watrous focuses on improving patient access to innovative medicines and simplifying health data collection, respectively. Additionally, Watrous provides strategic advisory services to Chronicled, aiding the life sciences industry in leveraging blockchain technology. Previous experience includes a Senior Advisor role at McKinsey & Company, where guidance was given to C-suite leaders on commercial strategies, and an Executive Advisor position at Waterhouse Brands. Watrous spent over two decades at Genentech, where significant roles included Senior Vice President and Business Unit Head, managing substantial product portfolios. Educational credentials include a Bachelor of Science in Pharmacy from Albany College of Pharmacy and Health Sciences and a Ph.D. in Pharmacy Administration from the University of South Carolina.

Location

Boston, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Chronicled

4 followers

We give industries and enterprises the tools to build blockchain powered supply chain ecosystems with built-in trust, automation, and privacy.